10x Genomics insider plans sale of 13,373 shares

10x Genomics, Inc. (TXG) is the issuer of common stock covered by a notice of proposed sale filed for the account of Benjamin J. Hindson.

Rhea-AI Filing Summary

10x Genomics, Inc. (TXG) is the issuer of common stock covered by a notice of proposed sale filed for the account of Benjamin J. Hindson. The filing contemplates the sale of 13,373 shares of TXG common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $870,849.76 and 120,212,296 shares of common stock outstanding. The shares relate to a Restricted Stock Unit Grant acquired on 08/21/2026, with services rendered as consideration.

Key Figures

Shares proposed to be sold: 13,373 shares of common stock Aggregate market value: $870,849.76 Shares outstanding: 120,212,296 shares +3 more

6 metrics

Shares proposed to be sold 13,373 shares of common stock Number of shares to be sold under Rule 144

Aggregate market value $870,849.76 Aggregate market value of shares proposed to be sold

Shares outstanding 120,212,296 shares Shares of common stock outstanding as referenced in the notice

RSUs acquired 26,277 Amount of securities acquired via Restricted Stock Unit Grant

RSU acquisition date 08/21/2026 Date of acquisition of Restricted Stock Unit Grant

Approximate sale date 08/24/2026 Approximate date of the proposed sale under Rule 144

Key Terms

Rule 144, Restricted Stock Unit Grant, Services Rendered

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Unit Grant financial

"Common Stock | 08/21/2026 | Restricted Stock Unit Grant | Issuer"

Services Rendered financial

"26277 | 08/24/2026 | Services Rendered"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for TXG disclose about planned share sales?

The notice discloses a proposed sale of 13,373 shares of 10x Genomics, Inc. (TXG) common stock for the account of Benjamin J. Hindson. The sale is to be executed through Morgan Stanley Smith Barney LLC and is associated with previously granted equity compensation.

What is the aggregate market value of TXG shares covered by this Form 144?

The filing lists an aggregate market value of $870,849.76 for the 13,373 shares of 10x Genomics, Inc. common stock proposed to be sold under Rule 144.

How many TXG shares are outstanding as referenced in this Form 144?

The Form 144 references 120,212,296 shares of 10x Genomics, Inc. common stock as outstanding, providing context for the size of the proposed sale relative to total shares.

Who is the person for whose account TXG securities are to be sold?

The securities are to be sold for the account of Benjamin J. Hindson. The document is signed by Randy Wu acting as Attorney-in-Fact for Benjamin J. Hindson.

What is the origin of the TXG shares listed to be sold in this Form 144?

The shares are related to a Restricted Stock Unit Grant acquired on 08/21/2026 from the issuer, 10x Genomics, Inc., with services rendered identified as the nature of payment.

Through which broker will the proposed TXG share sale be executed?

The proposed sale of 10x Genomics, Inc. common stock is to be executed through Morgan Stanley Smith Barney LLC Executive Services, with the securities listed for trading on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 06:06 PM EDT Accepted by SEC EDGAR 08/24/2026 - 06:05 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001786391
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	10x Genomics, Inc.
SEC File Number	001-39035
Address of Issuer	6230 STONERIDGE MALL ROAD PLEASANTON CALIFORNIA 94588
Phone	(925) 401-7300
Name of Person for Whose Account the Securities are To Be Sold	Hindson Benjamin J.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Services 200 W Civic Center Dr., 4th Floor Sandy UT 84070	13373	870849.76	120212296	08/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/21/2026	Restricted Stock Unit Grant	Issuer			26277	08/24/2026	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Randy Wu, as Attorney-in-Fact for Benjamin J. Hindson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)